Legal pitfalls in the diagnosis of prostate cancer

BJU International

Volumn 86, Issue 3, 2000, Pages 304-307

  Dunn, I B ^a   Kirk, David ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

HUMAN; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SHORT SURVEY;

BIOPSY; DEFENSIVE MEDICINE; HUMANS; INFORMED CONSENT; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; UROLOGY;

EID: 0033861405     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00298.x     Document Type: Short Survey

References (20)

1. 1 Hunter v. Hunley. Session Cases 1955: 200
2. 2 Smith EM, Hampel N, Ruff RL, Bodner DR, Resnick MI. Spinal cord compression secondary to prostate carcinoma. Treatment and prognosis. J Urol 1993; 149: 330-3
3. 3 Paul AB, Love C, Chisholm GD. The management of bilateral ureteric obstruction and renal failure in advanced prostate cancer 1994, 74, 642-5
4. 4 Bradshaw C, Donovan JL, George NJR et al. Guidelines on management of men with lower urinary tract symptoms suggesting bladder outflow obstruction. Report of a group set up by the British Association of Urological Surgeons, the Department of Health and the Surgical Audit Unit of the Royal College of Surgeons of England, January 1997
5. 5 Dearnaley DP, Kirby RS, Kirk D, Malone P, Simpson RJ, Williams G. Diagnosis and management of early prostate cancer. Report of a British Association of Urological Surgeons Working Party. Br J Urol 1999; 83: 18-33
6. 6 Bolam v. Friern Hospital Management Committee. 2 All England Reports 1957: 118
7. 7 Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I. High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia. Am J Med 1998; 104: 66-72
8. 8 Fowler FJ, Bin L, McNaughton Collins M et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med 1998; 104: 526-32
9. 9 Catalona WJ, Partin AW, Slawin KM et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease. JAMA 1998; 279: 1542-7
10. 10 Austoker J. Gaining informed consent for screening. Br Med J 1999; 319: 722-3
11. 11 General Medical Council. Seeking Patients' Consent. The Ethical Considerations. General Medical Council, February 1999
12. 12 Rodriguez LV, Terris MK. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol 1998; 160: 2115-20
13. 13 Kapoor DA, Klimberg IW, Malek GH, Wegenke JD et al. Single-dose ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998; 52: 552-8
14. 14 Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR. Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol 1998; 159: 1247-50
15. 15 Noguchi M, Yahara J, Koga H, Nakashima O, Noda S. Necessity of repeat biopsy in men for suspected prostate cancer. Int J Urol 1999; 6: 7-12
16. 16 Letran JL, Blase AB, Loberiza FR, Meyer CE, Ransom SD, Brawer MK. Repeat ultrasound-guided prostate needle biopsy: use of free to total prostate specific antigen ratio in predicting prostatic carcinoma. J Urol 1998; 160: 426-9
17. 17 Fleshner NE, O'Sullivan M, Fair WR. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol 1997; 158: 505-8
18. 18 Renfer LG, Schow D, Thompson IM, Optenberg S. Is ultrasound guidance necessary for transrectal prostate biopsy? J Urol 1995; 154: 1390-1
19. 19 Brat DJ, Wills ML, Lecksell KL, Epstein JI. How often are diagnostic features missed with less extensive histologic sampling of prostate needle biopsy specimens? Am J Surg Path 1999; 23: 257-62
20. 20 Herbert A. Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology. Report of a working party set up by the Royal College of Pathologists, British Society for Clinical Cytology and the National Health Service Cervical Screening Programme. National Health Service Cervical Screening Programme publication 1, October 1995:21